Abstract
Conventional radiotherapy is known to be an effective treatment approach even for "benign" pathologies. However, this kind of treatment yields a high potential for side effects. The Cyberknife, a robotic stereotactic radiotherapy device, enables to offset a large proportion of the disadvantages encountered with conventional radiotherapy essentially through the high precision of dose administration and sparing of healthy tissues. Therefore, it seems to be a treatment of choice in the approach of some benign intracranial diseases. We review published data on indications and outcome of Cyberknife for intracranial "non-malignant" disease.
MeSH terms
-
Adenoma / pathology
-
Adenoma / surgery
-
Epilepsy, Temporal Lobe / pathology
-
Epilepsy, Temporal Lobe / surgery
-
Glomus Jugulare Tumor / pathology
-
Glomus Jugulare Tumor / surgery
-
Humans
-
Intracranial Arteriovenous Malformations / pathology
-
Intracranial Arteriovenous Malformations / surgery
-
Meningeal Neoplasms / pathology
-
Meningeal Neoplasms / surgery
-
Meningioma / pathology
-
Meningioma / surgery
-
Pituitary Neoplasms / pathology
-
Pituitary Neoplasms / surgery
-
Quality of Life
-
Radiation Oncology* / instrumentation
-
Radiosurgery / instrumentation
-
Radiosurgery / methods*
-
Radiotherapy Dosage
-
Treatment Outcome
-
Trigeminal Neuralgia / pathology
-
Trigeminal Neuralgia / surgery